When Should I Start HRT?

When Should I Start HRT? Understanding the Hormone Therapy Timing Hypothesis

The timing hypothesis is the idea that when you start hormone replacement therapy may affect its risks and benefits. 

In general, healthy women who begin menopausal hormone therapy before age 60 or within about 10 years of menopause tend to have a more favorable risk-benefit profile than women who start much later. That does not mean there is a hard cutoff at age 60. It means timing, symptoms, health history, and personal risk should all be considered together.

At The Gabrielson Clinic for Women, we help women understand where they are in the menopause transition and whether hormone therapy may be appropriate for their symptoms and health goals.

Schedule an Appointment

What Is the HRT Timing Hypothesis?

The hormone replacement therapy timing hypothesis, sometimes called the critical window hypothesis, suggests that hormone therapy may have different effects depending on how close a woman is to menopause when treatment begins.

The main idea is simple: starting HRT closer to menopause is not the same as starting it many years later.

Current guidance often uses two markers when discussing this timing window:

• Younger than age 60
• Within about 10 years of the final menstrual period

The American College of Obstetricians and Gynecologists (ACOG) notes that some research suggests combined hormone therapy may protect against heart attacks in women who start within 10 years of menopause and before age 60. 

The FDA has also updated menopausal hormone therapy labeling to include consideration of treatment for moderate to severe symptoms in women younger than 60 or within 10 years of menopause.

Why Does HRT Timing Matter?

The body changes with age, and blood vessels, bones, metabolism, and other tissues may respond differently to estrogen depending on when treatment begins.

This helps explain why older hormone therapy studies sometimes reached different conclusions than research focused on younger women closer to menopause. For example, participants in the original Women’s Health Initiative (WHI), a large U.S. research program that studied ways to prevent major health problems in postmenopausal women, including the effects of hormone therapy, had an average age of about 63. Its early findings raised widespread concern, but later research showed that HRT risks and benefits can vary by age and timing. 

Many women seek treatment for hot flashes and night sweats in their late 40s or 50s. The HRT timing hypothesis suggests that starting treatment closer to menopause may have different effects because tissues may still be healthier and more responsive.

HRT Before Age 60 vs. Starting HRT Later

There is no single age when HRT suddenly becomes unsafe. The Menopause Society states that some women may continue hormone therapy after age 65 with appropriate counseling and risk assessment.

Is There a “Best Time” to Start Hormone Replacement Therapy?

There is no single best age for every woman.

The better question is: 

When do your symptoms, health history, and personal risks make treatment worth considering?

For many women, that conversation happens during perimenopause or within the first several years after menopause.

Hormone therapy may be especially worth discussing if you have:

Systemic estrogen remains the most effective treatment for hot flashes and night sweats, and it also helps protect against bone loss that occurs early in menopause.

The Timing Hypothesis & Heart Health

The timing hypothesis is most often discussed in relation to cardiovascular health.

Menopause is a time when cardiovascular risk factors can begin to rise. Research suggests that age, time since menopause, existing artery disease, and the type of hormone therapy may all affect cardiovascular outcomes.

For some healthy women who start hormone therapy closer to menopause, cardiovascular risks may be lower than they are for women who begin treatment much later.

That does not mean HRT should be prescribed only to prevent heart disease.

Hormone therapy is primarily used to treat menopause symptoms and, in some cases, help prevent bone loss. Heart health should be part of the overall risk assessment, not the sole reason for treatment.

What About HRT & Brain Health?

This is where the evidence is less certain.

Some observational research suggests that women who begin hormone therapy in midlife may have different cognitive outcomes than women who start much later. However, the evidence is not strong enough to recommend HRT solely to prevent dementia.

This is an important qualification. A 2025 review found no clear evidence that a specific timing window should be used to prescribe menopausal hormone therapy for cognitive protection.

The practical takeaway is:

While hormone replacement therapy is highly effective for managing menopause symptoms, it should not be started with the primary goal of preventing Alzheimer’s disease.

Why Timing Matters for Bone Health

Bone loss speeds up around menopause because estrogen levels fall.

Hormone therapy can help protect against this early postmenopausal bone loss. ACOG states that systemic estrogen helps protect against bone loss that occurs early in menopause and may help prevent osteoporosis.

This is another reason women should not wait until symptoms become unbearable before discussing menopause care.

Does the 10-Year HRT Rule Mean It Is Too Late After 10 Years?

No.

The “10-year rule” is a useful clinical guide, not a cut-off.

Starting systemic hormone therapy for the first time more than 10 years after menopause may require greater caution because age and cardiovascular risks have changed. But some women may still benefit from treatment after an individualized evaluation.

The same is true after age 60.

Does the Type of HRT Matter Too?

Yes.

Timing is only one part of the decision.

Hormone therapy may differ by:

The FDA’s recent labeling changes also emphasize that menopausal hormone therapy should be considered based on the individual patient rather than a one-size-fits-all rule.

Why the Women’s Health Initiative Changed the HRT Conversation

Many women still remember hearing that hormone therapy was dangerous.

Much of that fear stemmed from results of the Women’s Health Initiative in the early 2000s.

The study provided important safety information, but the women enrolled were, on average, older than the women who usually begin HRT for menopause symptoms. The FDA now specifically notes that the average participant was about 63 years old, while bothersome menopause symptoms often begin much earlier.

Later research helped scientists better understand that age and time since menopause matter when interpreting those results.

That is one reason the discussion around HRT today is more individualized than it was 20 years ago.

Updated FDA Guidance on Hormone Replacement Therapy

In February 2026, the FDA approved updated labeling for several menopausal hormone therapy products.

The changes removed the cardiovascular disease, breast cancer, and probable dementia statements from the boxed warning for those products while retaining relevant risk information elsewhere in the prescribing information. The agency also emphasizes considering age, timing, symptoms, and individual risk when discussing treatment.

This does not mean HRT is risk-free.

It means women and their healthcare providers should evaluate current evidence rather than relying on older, overly broad assumptions about hormone therapy.

When to See a Hormone Therapy Provider 

You do not need to wait until menopause symptoms become severe.

Consider scheduling an evaluation if:

• Hot flashes or night sweats are disrupting your day
• Poor sleep is affecting your energy or mood
• Your periods are becoming irregular
• You have vaginal dryness or discomfort
• You entered menopause early
• You are wondering whether HRT is right for you
• You stopped considering HRT years ago because you were worried about older safety warnings
• You are concerned that you may be approaching or past the usual HRT timing window

An evaluation does not commit you to hormone therapy. It gives you the information you need to make an informed decision.

Talk With an Iowa Menopause & Hormone Therapy Provider

If you are wondering when to start HRT, the answer should come from more than your age alone.

At The Gabrielson Clinic for Women, we can review your symptoms, menopause timeline, personal and family health history, and treatment goals. Together, we can discuss whether hormone therapy or another menopause treatment makes sense for you.

Don’t wait to request an appointment to talk about hormone replacement therapy in Iowa.

Schedule an Appointment